June 23 (Reuters) - Drugmaker SIGA Technologies said on Thursday it has received orders worth about $13 million for its oral antiviral drug Tpoxx, as monkeypox cases spread globally. (Reporting by Leroy Leo in Bengaluru; Editing by Amy Caren Daniel)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.79 USD | +1.74% | +5.40% | +56.96% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+56.96% | 625M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- SIGA Stock
- News SIGA Technologies, Inc.
- Siga Technologies gets orders worth $13 mln for antiviral drug